These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27641832)

  • 1. Do nanoparticles have a future in dermal drug delivery?
    Patzelt A; Mak WC; Jung S; Knorr F; Meinke MC; Richter H; Rühl E; Cheung KY; Tran NBNN; Lademann J
    J Control Release; 2017 Jan; 246():174-182. PubMed ID: 27641832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gradient-dependent release of the model drug TRITC-dextran from FITC-labeled BSA hydrogel nanocarriers in the hair follicles of porcine ear skin.
    Tran NBNN; Knorr F; Mak WC; Cheung KY; Richter H; Meinke M; Lademann J; Patzelt A
    Eur J Pharm Biopharm; 2017 Jul; 116():12-16. PubMed ID: 27693856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggered release of model drug from AuNP-doped BSA nanocarriers in hair follicles using IRA radiation.
    Lademann J; Richter H; Knorr F; Patzelt A; Darvin ME; Rühl E; Cheung KY; Lai KK; Renneberg R; Mak WC
    Acta Biomater; 2016 Jan; 30():388-396. PubMed ID: 26621698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follicular penetration of nanocarriers is an important penetration pathway for topically applied drugs].
    Lademann J; Richter H; Schanzer S; Meinke MC; Darvin ME; Schleusener J; Carrer V; Breuckmann P; Patzelt A
    Hautarzt; 2019 Mar; 70(3):185-192. PubMed ID: 30627746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in follicular drug delivery of nanoparticles.
    Patzelt A; Lademann J
    Expert Opin Drug Deliv; 2020 Jan; 17(1):49-60. PubMed ID: 31829758
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic polyglycerol and N-isopropylacrylamide based thermoresponsive nanogels as smart carriers for controlled delivery of drugs through the hair follicle.
    Sahle FF; Giulbudagian M; Bergueiro J; Lademann J; Calderón M
    Nanoscale; 2017 Jan; 9(1):172-182. PubMed ID: 27905610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of drug release of particles in hair follicles.
    Mak WC; Patzelt A; Richter H; Renneberg R; Lai KK; Rühl E; Sterry W; Lademann J
    J Control Release; 2012 Jun; 160(3):509-14. PubMed ID: 22516090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
    Lauterbach A; Müller-Goymann CC
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of topically applied nanocarriers into the hair follicles of dog and rat dorsal skin and porcine ear skin.
    Knorr F; Patzelt A; Darvin ME; Lehr CM; Schäfer U; Gruber AD; Ostrowski A; Lademann J
    Vet Dermatol; 2016 Aug; 27(4):256-e60. PubMed ID: 27229377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive Eudragit® L 100 nanoparticles promote cutaneous penetration and drug release on the skin.
    Dong P; Sahle FF; Lohan SB; Saeidpour S; Albrecht S; Teutloff C; Bodmeier R; Unbehauen M; Wolff C; Haag R; Lademann J; Patzelt A; Schäfer-Korting M; Meinke MC
    J Control Release; 2019 Feb; 295():214-222. PubMed ID: 30597246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery to hair follicles.
    Patzelt A; Lademann J
    Expert Opin Drug Deliv; 2013 Jun; 10(6):787-97. PubMed ID: 23530745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular transport route--research progress and future perspectives.
    Knorr F; Lademann J; Patzelt A; Sterry W; Blume-Peytavi U; Vogt A
    Eur J Pharm Biopharm; 2009 Feb; 71(2):173-80. PubMed ID: 19041720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery with topically applied nanoparticles: science fiction or reality.
    Lademann J; Richter H; Meinke MC; Lange-Asschenfeldt B; Antoniou C; Mak WC; Renneberg R; Sterry W; Patzelt A
    Skin Pharmacol Physiol; 2013; 26(4-6):227-33. PubMed ID: 23921109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery into the skin by degradable particles.
    Mak WC; Richter H; Patzelt A; Sterry W; Lai KK; Renneberg R; Lademann J
    Eur J Pharm Biopharm; 2011 Sep; 79(1):23-7. PubMed ID: 21457780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hair follicle: reservoir function and selective targeting.
    Blume-Peytavi U; Vogt A
    Br J Dermatol; 2011 Oct; 165 Suppl 2():13-7. PubMed ID: 21919898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery across intact and disrupted skin barrier: Identification of cell populations interacting with penetrated thermoresponsive nanogels.
    Rancan F; Giulbudagian M; Jurisch J; Blume-Peytavi U; Calderón M; Vogt A
    Eur J Pharm Biopharm; 2017 Jul; 116():4-11. PubMed ID: 27865989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roxithromycin-loaded lipid nanoparticles for follicular targeting.
    Wosicka-Frąckowiak H; Cal K; Stefanowska J; Główka E; Nowacka M; Struck-Lewicka W; Govedarica B; Pasikowska M; Dębowska R; Jesionowski T; Srčič S; Markuszewski MJ
    Int J Pharm; 2015 Nov; 495(2):807-15. PubMed ID: 26456292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the cutaneous penetration behavior of dexamethasone loaded to nano-sized lipid particles by EPR spectroscopy, and confocal Raman and laser scanning microscopy.
    Lohan SB; Saeidpour S; Solik A; Schanzer S; Richter H; Dong P; Darvin ME; Bodmeier R; Patzelt A; Zoubari G; Unbehauen M; Haag R; Lademann J; Teutloff C; Bittl R; Meinke MC
    Eur J Pharm Biopharm; 2017 Jul; 116():102-110. PubMed ID: 28043865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects.
    Mathes C; Melero A; Conrad P; Vogt T; Rigo L; Selzer D; Prado WA; De Rossi C; Garrigues TM; Hansen S; Guterres SS; Pohlmann AR; Beck RCR; Lehr CM; Schaefer UF
    J Control Release; 2016 Feb; 223():207-214. PubMed ID: 26686081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.